Press Release – Health Research Council Newly funded research will examine over 10,000 brain scans to identify the key brain processes underlying Attention Deficit Hyperactivity Disorder (ADHD), with the overall aim of developing a reliable biomarker to detect cognitive differences associated …
Newly funded research will examine over 10,000 brain scans to identify the key brain processes underlying Attention Deficit Hyperactivity Disorder (ADHD), with the overall aim of developing a reliable ‘biomarker’ to detect cognitive differences associated with ADHD.
Around five per cent of New Zealand children have ADHD, a common neurodevelopmental disorder which can affect educational and employment attainment later in life. ADHD is also the most frequent diagnosis given to Māori children at mental health services. Yet, currently there are no reliable biomarkers for the cognitive differences associated with ADHD, making it difficult to detect the disorder early as well as to asse
Friday, 28 May 2021, 6:12 am
Newly funded research will examine over 10,000 brain
scans to identify the key brain processes underlying
Attention Deficit Hyperactivity Disorder (ADHD), with the
overall aim of developing a reliable ‘biomarker’ to
detect cognitive differences associated with
ADHD.
Around five per cent of New Zealand children
have ADHD, a common neurodevelopmental disorder which can
affect educational and employment attainment later in life.
ADHD is also the most frequent diagnosis given to Māori
children at mental health services. Yet, currently there are
no reliable biomarkers for the cognitive differences
associated with ADHD, making it difficult to detect the
disorder early as well as to assess treatment effectiveness
The Medical Research Institute of New Zealand (MRINZ) has received extraordinary recognition at the Australian Clinical Trials Alliance (ACTA) 2021 Trial of the Year Awards, announced in Melbourne last night. MRINZ played a senior role in three clinical .
Press Release – Medical Research Institute of New Zealand The Medical Research Institute of New Zealand (MRINZ) has received extraordinary recognition at the Australian Clinical Trials Alliance (ACTA) 2021 Trial of the Year Awards, announced in Melbourne last night. MRINZ played a senior role in three clinical …
The Medical Research Institute of New Zealand (MRINZ) has received extraordinary recognition at the Australian Clinical Trials Alliance (ACTA) 2021 Trial of the Year Awards, announced in Melbourne last night.
MRINZ played a senior role in three clinical trials which won five of the seven ACTA Awards, which celebrate the vital place trials have in advancing clinical practice and saving or improving patients’ lives every year.
Community Scoop » Medical Research Institute Of New Zealand Wins Big At Australian Clinical Trials Alliance 2021 Trial Of The Year Awards scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.